Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-25-000049

PRESIDENT AND CFO acquired 4,777 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
GUGGENHIME ANDREW PRESIDENT AND CFO 2025-04-07 Option exercise +4,777 $20.93 $99,983 131,950 D
Derivatives
GUGGENHIME ANDREW PRESIDENT AND CFO 2025-04-07 Option exercise · Stock Option (right to buy) −4,777 121,115 D
Loading xslF345X05/wk-form4_1744200305.xml…